Minimally Invasive Surgical Instruments Market Size, Share, and Trends 2024 to 2034

Minimally Invasive Surgical Instruments Market Size and Growth 2024 to 2033

The global minimally invasive surgical instruments market size was estimated at USD 31.08 billion in 2023 and it is expected to hit USD 88.25 billion by 2033, poised to grow at a CAGR of 11% from 2024 to 2033.

Minimally Invasive Surgical Instruments Market Key Takeaways

• North America led the global market with the highest market share of 44.14% in 2023.
• By device, the handheld instruments segment has held the largest market share in 2023.
• By application, the orthopedic segment captured the biggest revenue share of 25% in 2023.
• By end use, the hospital segment registered a maximum market share of 69% in 2023.

U.S. Minimally Invasive Surgical Instruments Market Size and Growth 2024 to 2033

The U.S. minimally invasive surgical instruments market size was estimated at USD 9.62 billion in 2023 and is predicted to be worth around USD 28.71 billion by 2033, at a CAGR of 11.6% from 2024 to 2033.

North America led the market in 2023 with revenue share of 44.14%. The minimally invasive surgical instruments market in this region is expanding due to the growing prevalence of various kind of disorders. Heart disease is the biggest cause of mortality in the U.S. as per an updated report published by the Centers for Disease Control and Prevention in September 2022. About 18.2 million American adults aged 20 and above have coronary artery disease and approximately 360,900 people died from coronary heart disorder in 2019. In addition, adoption of innovative technologies is also driving the growth of minimally invasive surgical instruments market in North America region.

Asia-Pacific, on the other hand, is expected to develop at the fastest rate during the forecast period. China and Japan dominate the minimally invasive surgical instruments market in Asia-Pacific region. The factors such as rapid urbanization, growing geriatric population, and growing trend of medical tourism are boosting the growth of minimally invasive surgical instruments market in this region. In addition, the increase in healthcare expenditure is paving way for the expansion of Asia-Pacific minimally invasive surgical instruments market.

Asia Pacific Minimally Invasive Surgical Instruments Market Size and Growth 2024 to 2033

The Asia Pacific minimally invasive surgical instruments market size was calculated at USD 6.90 billion in 2023 and is projected to expand around USD 20.92 billion by 2033, poised to grow at a CAGR of 11.7% from 2024 to 2033.

Minimally Invasive Surgical Instruments Market Growth Factors

Due to benefits of minimally invasive surgical procedures such as fewer serious operative and post operative problems and quicker recovery times are driving the demand for minimally invasive surgical instruments in the global market. In addition, the growing prevalence of chronic disorders is also driving the growth of the global minimally invasive surgical instruments market. As per the World Health Organization (WHO) statistics report for 2021, non-communicable disorders often known as chronic disorders kill around 41 million people each year, accounting for roughly 71% of all deaths worldwide. According to the same source, non-communicable disorders claim the lives of nearly 15 million people aged 30 to 69 years old every year around the globe. Thus, the rising burden of non-communicable diseases is driving the demand for minimally invasive surgical operations. This is directly impacting the expansion of global minimally invasive surgical instruments market over the forecast period.

The impact of the coronavirus outbreak on the growth of global minimally invasive surgical instruments market was quite negative. This is attributed to the supply chain disruptions and trade restrictions. In addition, the hospitals visits have been lowered in number as compared to previous year. Thus, the growing number of vaccinations had negative outlook on the expansion of global minimally invasive surgical instruments market.

The major market players are adopting marketing strategies for the development of global minimally invasive surgical instruments market. The key strategies such as new product launch, mergers, collaborations, and acquisitions are creating market position for market players in global minimally invasive surgical instruments market. For example, Fujifilm Medical Systems USA Inc. introduced its ELUXEO surgical system in July 2020, which combines the company’s endoscopic and minimally invasive surgeries and allows surgeons to perform all type of endoscopic surgeries from a single component with improved visualization.

The growth of global minimally invasive surgical instruments market is attributed to the growing research and development initiatives for the launch of new minimally invasive surgical instruments in the global market. In addition, the government of developed regions is also investing in the development of minimally invasive surgical instruments. All of these aforementioned factors are boosting the growth of the global minimally invasive surgical instruments market.

Minimally Invasive Surgical Instruments Market Scope

Device Insights

The handheld instruments segment accounted for the largest revenue share in 2023. The handheld instruments segment is growing due to technological developments especially due to adoption of robotics. These minimally invasive surgical instruments are cost effective when compared to other types of minimally invasive surgical instruments. In addition, handheld instruments are easy to operate. All of these aforementioned factors are driving the growth of the segment.

The electrosurgical devices segment is expected to witness strong growth during forecast period. Due to rising frequency of chronic disorders, the ageing population, and the rise in the number of minimally invasive surgical processes, the electrosurgical devices segment is predicted to grow fast throughout the projected period. The demand for cosmetic operations is growing and one key driver driving demand and acceptance of electrosurgical devices in the global market is the rising use of electrosurgical devices in minimally invasive cosmetic surgeries.

Application Insights

The orthopedic segment dominated the market in 2023 with a 25% revenue share. The orthopedic minimally invasive surgical processes are quite less risky as compared to traditional surgical methods. As a result, minimally invasive surgical instruments are used in critical orthopedic operations. Due to these factors, minimally invasive surgical instruments are highly adopted by surgeons and orthopedic surgeons.

The cardiac surgery segment is projected to hit strong growth from 2024 to 2033. The minimally invasive operations have a number of advantages over traditional surgeries including less pain and blood loss. In addition, the growing prevalence of cardiovascular disorders is considered as key factor driving the demand for minimally invasive surgical instruments for cardiac surgery.

End Use Insights

The hospital segment accounted revenue share of around 69% in 2023. The market for minimally invasive surgical instruments is expanding due to growing number of hospitals globally. Moreover, the government all around the globe is taking efforts for the development of healthcare facilities. In addition, the rising prevalence of chronic disorders are also contributing towards the growth of the segment.

The ambulatory surgical centers segment is expected to hit remarkable growth during the forecast period. The growing number of ambulatory surgical centers is driving the growth of global minimally invasive surgical instruments market. As per the government records, there are 5,500 ambulatory surgical centers in the U.S. The ambulatory surgical centers are considered as cost effective option as compared to hospitals. The favorable reimbursement policies is driving the adoption of minimally invasive surgical instruments in ambulatory surgical centers on a large scale.

Minimally Invasive Surgical Instruments Market Recent Developments

• Johnson & Johnson introduced the ECHELON+Stapler in March 2021.
• Ambu Inc. gained Health Canada certification for aScope 4 Cysto, a single use endoscopes platform for urology in April 2021.
• Titan Spine was bought by Medtronic PLC in June 2019. Medtronic’s position as a worldwide leader in procedural solutions for spine surgery was bolstered by this acquisition. 

Minimally Invasive Surgical Instruments Market Companies

• The Johns Hopkins Hospital
• Apollo Hospitals Enterprise Ltd.
• The General Hospital Corporation
• Bedfordshire Hospitals
• Stanford Healthcare
• Circle Health Ltd.
• Singapore General Hospital Ltd.
• Manipal Health Enterprises Pvt. Ltd
• Mount Elizabeth Hospital
• King Fahd Medical City 

Segments Covered in the Report

By Device

• Handheld Instruments
• Graspers
• Retractors/Elevators
• Suturing Instruments
• Dilators
• Other
• Inflation Devices
• Balloons
• Balloon Inflation Devices
• Surgical Scope
• Laparoscopes
• Urology Endoscopes
• Arthroscopes
• Neuroendoscopes
• Other
• Cutter Instruments
• Trocars
• Other Cutting Instruments
• Guiding Devices
• Guiding Catheters
• Guidewires
• Electrosurgical Devices
• Electrosurgical Instruments
• Electrocautery Device
• Auxiliary Devices
• Monitoring and Visualization Devices

By Application

• Cardiac
• Gastrointestinal
• Orthopedic
• Vascular
• Gynecological
• Urological
• Thoracic
• Cosmetic
• Dental
• Others

By End Use

• Hospitals
• Ambulatory Surgical Centers

 By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa